Resverlogix Corp

Closed
4820 Richard Rd SW
Calgary, AB T3E 6L1

Resverlogix Corp, based in Calgary, AB, is a late-stage clinical biotechnology company dedicated to enhancing the lives of patients with chronic illnesses through innovative epigenetic therapeutics. Its lead product, Apabetalone, is currently undergoing late-stage clinical evaluation for high-risk cardiovascular disease and post COVID-19 conditions.

Founded in 2001 by Donald McCaffrey and Norman Wong, Resverlogix focuses on developing value-based health solutions and has received Breakthrough Therapy designation from the US FDA for Apabetalone, positioning itself as a global leader in modern medicine. The company's BETonMACE clinical trial is recognized as the most advanced epigenetic drug trial outside of oncology.

Generated from the website

Own this business?
See a problem?

You might also like

CanadaAlbertaCalgaryResverlogix Corp

Partial Data by Infogroup (c) 2024. All rights reserved.

Partial Data by Foursquare.